GPCR
Structure Therapeutics Inc.
NASDAQHealthcareBiotechnologyUS
Rating:C+
Company Profile
CEO
Raymond C. Stevens
IPO Date
2023-02-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Structure Therapeutics Inc.
CEO
Raymond C. Stevens
IPO Date
2023-02-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 23,634 |
| $0.00 |
| 15 Jul 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | M-Exempt | Disposed | 23,634 | $0.34 |
| 15 Jul 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | C-Conversion | Acquired | 7,878 | $0.00 |
| 15 Jul 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | S-Sale | Disposed | 6,278 | $0.00 |
| 15 Jul 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | S-Sale | Disposed | 1,600 | $0.00 |
| 29 Jun 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | M-Exempt | Acquired | 23,634 | $0.34 |
| 29 Jun 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | C-Conversion | Disposed | 23,634 | $0.00 |
| 29 Jun 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | M-Exempt | Disposed | 23,634 | $0.34 |
| 29 Jun 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | C-Conversion | Acquired | 7,878 | $0.00 |